Mike Matson
Stock Analyst at Needham
(3.18)
# 1,185
Out of 4,964 analysts
532
Total ratings
45.07%
Success rate
1.65%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Reiterates: Hold | n/a | $116.73 | - | 12 | Aug 25, 2025 | |
| AORT Artivion | Maintains: Buy | $45 → $50 | $43.81 | +14.13% | 19 | Aug 22, 2025 | |
| IMDX Insight Molecular Diagnostics | Reiterates: Buy | $4.25 | $2.51 | +69.32% | 1 | Aug 18, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $91.96 | - | 21 | Aug 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.20 | +150.00% | 21 | Aug 13, 2025 | |
| HAE Haemonetics | Maintains: Buy | $84 → $68 | $54.34 | +25.14% | 14 | Aug 7, 2025 | |
| ENOV Enovis | Maintains: Buy | $57 → $49 | $30.59 | +60.18% | 16 | Aug 7, 2025 | |
| SYK Stryker | Maintains: Buy | $442 → $448 | $389.67 | +14.97% | 9 | Aug 1, 2025 | |
| INMD InMode | Reiterates: Hold | n/a | $14.92 | - | 20 | Jul 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $44 → $45 | $37.22 | +20.90% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $8 | $7.21 | +10.96% | 26 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $108 | $90.05 | +19.93% | 30 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $41.33 | +16.14% | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $53.73 | +13.53% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $105.75 | +8.75% | 30 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $66.62 | - | 21 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $7.95 | +50.94% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $55.45 | +15.42% | 26 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $21.44 | +95.90% | 23 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $41 | $29.95 | +36.89% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $34.34 | - | 21 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $140.95 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.78 | +46.44% | 20 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $127.04 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $244.77 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $126.22 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $271.68 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $105.06 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $275.38 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $16.62 | +152.71% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $61.13 | +22.69% | 1 | Feb 18, 2021 |
TransMedics Group
Aug 25, 2025
Reiterates: Hold
Price Target: n/a
Current: $116.73
Upside: -
Artivion
Aug 22, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $43.81
Upside: +14.13%
Insight Molecular Diagnostics
Aug 18, 2025
Reiterates: Buy
Price Target: $4.25
Current: $2.51
Upside: +69.32%
Medtronic
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $91.96
Upside: -
Lucid Diagnostics
Aug 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.20
Upside: +150.00%
Haemonetics
Aug 7, 2025
Maintains: Buy
Price Target: $84 → $68
Current: $54.34
Upside: +25.14%
Enovis
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $30.59
Upside: +60.18%
Stryker
Aug 1, 2025
Maintains: Buy
Price Target: $442 → $448
Current: $389.67
Upside: +14.97%
InMode
Jul 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.92
Upside: -
AtriCure
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $37.22
Upside: +20.90%
Jul 29, 2025
Maintains: Buy
Price Target: $8.5 → $8
Current: $7.21
Upside: +10.96%
Jul 18, 2025
Reiterates: Buy
Price Target: $108
Current: $90.05
Upside: +19.93%
Jun 13, 2025
Reiterates: Buy
Price Target: $48
Current: $41.33
Upside: +16.14%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $53.73
Upside: +13.53%
May 28, 2025
Reiterates: Buy
Price Target: $115
Current: $105.75
Upside: +8.75%
May 28, 2025
Reiterates: Hold
Price Target: n/a
Current: $66.62
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $7.95
Upside: +50.94%
May 13, 2025
Reiterates: Buy
Price Target: $64
Current: $55.45
Upside: +15.42%
May 8, 2025
Reiterates: Buy
Price Target: $42
Current: $21.44
Upside: +95.90%
May 8, 2025
Maintains: Buy
Price Target: $51 → $41
Current: $29.95
Upside: +36.89%
Apr 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $34.34
Upside: -
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $140.95
Upside: -
Apr 10, 2025
Reiterates: Buy
Price Target: $7
Current: $4.78
Upside: +46.44%
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $127.04
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $244.77
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $126.22
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $271.68
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $105.06
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $275.38
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $16.62
Upside: +152.71%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $61.13
Upside: +22.69%